Dr. Brittany Seepersad is a Dallas, Texas based nurse practitioner. Active license number of Dr. Brittany Seepersad is 1145357 in Texas. Her current practice location is 18101 Preston Rd Ste 201, Dallas. Patients can reach her at 972-584-9554. Dr. Brittany Seepersad is ARNP, FNP-BC and her NPI number (Unique professional ID assigned by NPPES) is 1427810506. Dr. Brittany Seepersad has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Dr. Brittany Seepersad speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1427810506
NPI Enumeration Date:
25 Jan, 2024
NPI Last Update On:
25 Jan, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Brittany Seepersad are as mentioned below.
License Number
Specialization
State
Status
1145357
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Brittany Seepersad 2678 Annalea Cove Dr, Lewisville, Texas
Zip:
75056-4182
Phone Number:
904-426-7249
Patients can reach Dr. Brittany Seepersad at 18101 Preston Rd Ste 201, Dallas, Texas or can call to book an appointment on 972-584-9554.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.